Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2008 1
2009 1
2010 2
2011 2
2012 3
2014 5
2015 1
2016 2
2017 1
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10.
Seegar TCM, Killingsworth LB, Saha N, Meyer PA, Patra D, Zimmerman B, Janes PW, Rubinstein E, Nikolov DB, Skiniotis G, Kruse AC, Blacklow SC. Seegar TCM, et al. Among authors: Janes PW. Cell. 2017 Dec 14;171(7):1638-1648.e7. doi: 10.1016/j.cell.2017.11.014. Epub 2017 Dec 7. Cell. 2017. PMID: 29224781 Free PMC article.
EphA3 biology and cancer.
Janes PW, Slape CI, Farnsworth RH, Atapattu L, Scott AM, Vail ME. Janes PW, et al. Growth Factors. 2014 Dec;32(6):176-89. doi: 10.3109/08977194.2014.982276. Epub 2014 Nov 13. Growth Factors. 2014. PMID: 25391995 Review.
The role of proteases in regulating Eph/ephrin signaling.
Atapattu L, Lackmann M, Janes PW. Atapattu L, et al. Among authors: Janes PW. Cell Adh Migr. 2014;8(4):294-307. doi: 10.4161/19336918.2014.970026. Cell Adh Migr. 2014. PMID: 25482632 Free PMC article. Review.
PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling.
Mansour M, Nievergall E, Gegenbauer K, Llerena C, Atapattu L, Hallé M, Tremblay ML, Janes PW, Lackmann M. Mansour M, et al. Among authors: Janes PW. J Cell Sci. 2016 Jan 15;129(2):277-89. doi: 10.1242/jcs.174490. Epub 2015 Dec 7. J Cell Sci. 2016. PMID: 26644181 Free article.
Eph receptor signalling: from catalytic to non-catalytic functions.
Liang LY, Patel O, Janes PW, Murphy JM, Lucet IS. Liang LY, et al. Among authors: Janes PW. Oncogene. 2019 Sep;38(39):6567-6584. doi: 10.1038/s41388-019-0931-2. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406248 Review.
Antibody Targeting of Eph Receptors in Cancer.
Janes PW, Vail ME, Gan HK, Scott AM. Janes PW, et al. Pharmaceuticals (Basel). 2020 May 8;13(5):88. doi: 10.3390/ph13050088. Pharmaceuticals (Basel). 2020. PMID: 32397088 Free PMC article. Review.
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth.
Atapattu L, Saha N, Chheang C, Eissman MF, Xu K, Vail ME, Hii L, Llerena C, Liu Z, Horvay K, Abud HE, Kusebauch U, Moritz RL, Ding BS, Cao Z, Rafii S, Ernst M, Scott AM, Nikolov DB, Lackmann M, Janes PW. Atapattu L, et al. Among authors: Janes PW. J Exp Med. 2016 Aug 22;213(9):1741-57. doi: 10.1084/jem.20151095. Epub 2016 Aug 8. J Exp Med. 2016. PMID: 27503072 Free PMC article.
A mathematical model for eph/ephrin-directed segregation of intermingled cells.
Aharon R, Janes PW, Burgess AW, Hamza K, Klebaner F, Lackmann M. Aharon R, et al. Among authors: Janes PW. PLoS One. 2014 Dec 1;9(12):e111803. doi: 10.1371/journal.pone.0111803. eCollection 2014. PLoS One. 2014. PMID: 25436892 Free PMC article.
Concepts and consequences of Eph receptor clustering.
Janes PW, Nievergall E, Lackmann M. Janes PW, et al. Semin Cell Dev Biol. 2012 Feb;23(1):43-50. doi: 10.1016/j.semcdb.2012.01.001. Epub 2012 Jan 12. Semin Cell Dev Biol. 2012. PMID: 22261642 Review.
Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth.
To C, Farnsworth RH, Vail ME, Chheang C, Gargett CE, Murone C, Llerena C, Major AT, Scott AM, Janes PW, Lackmann M. To C, et al. Among authors: Janes PW. PLoS One. 2014 Nov 24;9(11):e112106. doi: 10.1371/journal.pone.0112106. eCollection 2014. PLoS One. 2014. PMID: 25420155 Free PMC article.
23 results
Jump to page